Skip to content

Study · In vitro (cells) · mouse · 1986

1 result

Alterations in bone marrow cell cycle kinetics by diphenylhydantoin and folate deficiency are restored by thymic peptides.

Tucker AN, Hong L, Boorman GA, Luster MI

Thymus1 Jan 1986Cited by 4 (Europe PMC)

PMID3750382 (opens in a new tab)PepBankPUB-03750382

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In mouse progenitor stem cells in vitro, FTS protected CFU-GM from diphenylhydantoin inhibition.

    In plain wordsIn lab tests with mouse stem cells, FTS protected blood-cell progenitors from inhibition by diphenylhydantoin.

    Outcome
    IncreaseProtection from DPH inhibition
    Study

    mousen: not reported in source

    CFU-GM progenitor stem cells exposed to diphenylhydantoin
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymosin and the thymic peptide, FTS (facteur thymique serique), were also able to protect the progenitor stem cell, CFU-GM, from DPH inhibition in vitro, indicating a direct effect of both drug and thymic factors on stem cells.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.